Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABN401 in Advanced Solid Tumors with c-MET Aberration
NCT05882292Phase 2Recruiting
- Sponsor
- Yonsei University
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vabametkib in solid tumor (advanced stage), sponsored by Yonsei University. Started Nov 2023; status: recruiting.
02
Drugs
vabametkib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05882292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05882292.